Filter
7081
Filtered Results: 7081
Text search:
Partners
in
Health,
World
Health
Organization
Featured
Recommendations
600
New Publications
2095
Language
Document type
No document type
4252
Studies & Reports
1091
Guidelines
741
Manuals
331
Strategic & Response Plan
296
Fact sheets
113
Training Material
100
Situation Updates
88
Resource Platforms
25
Brochures
15
Infographics
14
Online Courses
7
Videos
5
App
2
Dashboards/Maps
1
Countries / Regions
Global
273
India
236
Kenya
226
Sierra Leone
187
Ethiopia
173
Uganda
173
Nigeria
164
Liberia
160
Nepal
138
Myanmar / Burma
127
Zambia
116
South Africa
112
Rwanda
111
Syria
106
Bangladesh
106
Malawi
106
Africa
105
Western and Central Europe
104
Tanzania
103
Ghana
92
Ukraine
82
Congo, Democratic Republic of
81
South Sudan
75
Philippines
66
Latin America and the Carribbean
66
Namibia
59
Zimbabwe
56
Lesotho
56
Cambodia
55
South–East Asia Region
49
Guinea
48
Haiti
46
Indonesia
46
Asia
45
Mozambique
44
Yemen
41
Eastern Europe
41
East and Southern Africa
39
Senegal
38
West and Central Africa
38
Cameroon
32
Afghanistan
32
Botswana
31
Middle East and North Africa
31
Burkina Faso
28
Germany
28
Pakistan
26
Russia
24
Central African Republic
23
Somalia
22
Jordan
20
Lebanon
20
Eswatini/ Swaziland
20
Brazil
19
Mali
18
Venezuela
18
Thailand
17
Sudan
17
Madagascar
17
Western Pacific Region
17
Iraq
15
Benin
15
Eastern Europe and Central Asia
15
Colombia
14
Tajikistan
13
Moldova
12
Vietnam
12
Sri Lanka
11
Laos
11
Albania
10
Côte d’Ivoire / Ivory Coast
9
China
9
Libya
9
Angola
9
Georgia
9
Niger
8
Turkey
8
USA
7
North Macedonia
7
Togo
6
Chad
6
Gambia
6
Peru
6
Burundi
6
Palestine
6
Timor Leste/ East Timor
6
Iran
6
Guinea-Bissau
5
Egypt
5
Papua New Guinea
5
Greece
5
Mexico
5
Poland
5
Southern Africa
5
Kyrgyzstan
5
North America
5
Jamaica
5
Serbia
4
Armenia
4
Romania
4
Kazakhstan
4
Turkmenistan
4
Japan
4
Morocco
3
Malaysia
3
Mauritania
3
Hungary
3
Croatia
3
Honduras
3
Paraguay
3
Bhutan
3
Mauritius
3
Tunisia
3
Portugal
3
Spain
3
Belarus
3
Saudi Arabia
2
Argentina
2
Switzerland
2
El Salvador
2
Bolivia
2
Guatemala
2
North Korea
2
Italy
2
Djibouti
2
Canada
2
Bulgaria
2
United Kingdom
2
Azerbaijan
2
Israel
2
Singapore
1
Vanuatu
1
Dominican Republic
1
Austria
1
Ecuador
1
Cape Verde
1
Chile
1
Other region
1
Fiji
1
Solomon Islands
1
Mongolia
1
Qatar
1
Estonia
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Gabon
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
Algeria
1
Bosnia and Herzegovina
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2689
Clinical Guidelines
432
Women & Child Health
413
Public Health
369
Key Resources
352
Capacity Building
134
Pharmacy & Technologies
45
Annual Report MEDBOX
3
Toolboxes
HIV
684
COVID-19
490
Mental Health
426
TB
333
Disability
303
Conflict
262
Ebola
244
Rapid Response
240
Planetary Health
229
Caregiver
170
AMR
167
Refugee
148
NTDs
143
Global Health Education
142
Natural Hazards
99
Pharmacy
84
Zika
75
Health Financing Toolbox
74
NCDs
70
Cholera
48
Polio
42
Specific Hazards
26
Social Ethics
22
Typhoon
3
Health Financing
3
South Sudan
2
Antimicrobial Resistance Resource Platform
recommended
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.
AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections ha...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID...
This document provides interim recommendations for the surveillance of Zika virus infection, microcephaly and Guillain-Barré syndrome, in four different contexts and describes reporting requirements to WHO. Transmission refers to vector-borne trans...
Zika virus is primarily transmitted by the Aedes species of mosquito which is also responsible for the spread of dengue, Chikungunya and yellow fever viruses. In most areas, the primary vector of these viruses is Aedes aegypti, with Aedes albopictus...
Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy <... adults with signs and symptoms of pulmonary TB, especially when further testing of sputum smear-negative specimens is necessary.
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in...
Novel coronavirus will disproportionately impact world’s 70 million displaced people
Report recommends stopping asylum seeker deportations, prioritising hygiene and refugee camp decongestion, better communication
Displaced people must be...
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean,...
People-centered approaches that help communities maintain protective behaviours and follow guidelines set out by public health and government agencies are more important than ever. The evidence is clear, communities play a role ... preventing and controlling epidemics and they are best able to take action and slow or stop the spread of disease when properly engaged and empowered. This toolbox in 2 parts offers best practice approaches to community engagement with families. Promoting individual and joint responsibilities for the safety of the family, this toolbox aims to bring families and households together to manage shared risks and agree to safe behaviours critical for their safety and the safety of their community.
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries face challenges with erratic vaccine supplies, use of multiple vaccine products with different charact...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strateg...
9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published ... 2017 and provides the latest practical guidance on use of newly recommended diagnostics as well as guidance in key technical areas, including quality assurance and quality management systems, specimen collection and registration, procurement and supply-chain management, diagnostic connectivity, biosafety, data management, human resources, strategic planning, and model algorithms. The key changes are:
inclusion of recent or updated WHO recommendations for tests to diagnose TB and detect drug resistance;
alignment with the latest WHO critical concentrations for phenotypic drug-susceptibility testing (DST) and the new definitions of pre-XDR-TB and XDR-TB;
updated information on building quality-assured TB testing and management capacity using the Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) approach (Score-TB package1);
updated information on assessing, analysing and optimising TB diagnostic networks; and
updated information on the use of next-generation sequencing (NGS) to detect mutations associated with drug resistance for surveillance purposes.
The document also provides references to resources and tools relevant for work on laboratory strengthening.
This Rapid Communication aims to inform national TB programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in...
Since the last situation report on the multi-country outbreak of cholera was published on 6 July 2023 (covering data reported until 15 of June), and as of 15 July 2023, one new outbreak of cholera was reported from India on 15 May 2023. In total, 25...
Suicides take a high toll. Over 800 000 people die by suicide every year and it is the second leading cause of
death in 15-29-year-olds. Most suicides occur in low- and middle-income countries wher...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available ... all settings, especially in rural areas of low-income countries, making it difficult to identify and treat patients. Additionally, there is controversy about the role, type and duration of anthelmintic, antiinflammatory and antiepileptic drug (AED) treatments for different forms of neurocysticercosis.
These guidelines were developed to assist health-care providers in appropriate, evidence-based management of parenchymal neurocysticercosis. The guidelines do not address other forms of neurocysticercosis and do not include management of extraparenchymal disease (including cysticerci in the cerebral ventricles or subarachnoid space). The aim of the guidance is to improve decision-making to ensure appropriate patient care and to avoid misdiagnoses and inappropriate treatment of patients with neurocysticercosis.
Overview
Learning objectives
• Promote respect and dignity for children and adolescents with mental and behavioural
disorders.
• Know common presentations of children and adolescents with mental and behavioural
disorders.
• Know assessment principles of child and adolescents with mental ...
Global tuberculosis report 2022
recommended
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done ... the context of global TB commitments, strategies and targets.
The 2022 edition of the report is as usual, based primarily on data gathered by WHO from national ministries of health in annual rounds of data collection. In 2022, 202 countries and territories with more than 99% of the world’s population and TB cases reported data
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and thr...
